Antipsychotic Drugs Market Size, Share and Industry Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Others), By Therapeutic Class (First Generation, Second Generation, Third Generation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

  • TBI727589
  • August 25, 2020
  • Global
  • 132 pages
  • ROIF Expert
                                          

We have updated Antipsychotic Drugs Market with respect to COVID-19 Business Impact. Inquire before buying This report focuses on the Antipsychotic Drugs market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Antipsychotic Drugs market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.

Global Antipsychotic Drugs Market: Segment Analysis

The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.

Global Antipsychotic Drugs Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.

Global Antipsychotic Drugs Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.

Segmentation

By Disease

  • Schizophrenia
  • Bipolar Disorder
  • Unipolar Depression
  • Dementia
  • Others

By Therapeutic Class

  • First Generation
  • Second Generation
  • Third Generation

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Antipsychotic Drugs Market Players

  • H. Lundbeck A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • AstraZeneca
  • ALLERGAN
  • Vanda Pharmaceuticals Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Alkermes plc
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Other Prominent Players

Key Industry Developments

In July 2018

, the new antipsychotic drug called Perseris, an extended-release injectable form of risperidone from Indivior PLC won the FDA approval for the treatment of schizophrenia

In May 2019

, the FDA approved ALLERGANs antipsychotic drug Vraylar for the treatment of depression in adults diagnosed with bipolar disorder, which makes the drug the first ever approved to treat the full spectrum of symptoms in bipolar I

In April 2018

, Otsuka Pharmaceutical Co., Ltd. announced the launch of REXULTI tablets for the treatment of schizophrenia in Japan  

Table of Content
Chapter 1. Methodology and Scope 
1.1. Research Methodology 
1.2. Research Scope & Assumptions 
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Antipsychotic Drugs Market
3.1. Market Segmentation 
3.2. Market Size and Growth Prospects, 2019 - 2029 
3.3. Value Chain Analysis 
3.4. Market Dynamics 
3.4.1. Market driver analysis 
3.4.2. Market restraint analysis
Chapter 4. Market Size by Application
4.1 Antipsychotic Drugs Market Consumption by Application (2015-2020) 
4.2 Antipsychotic Drugs Market Consumption by Application (2020-2029) 

|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form